Nuvation Bio Inc. Quarterly Operating Income (Loss) in USD from Q1 2020 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Nuvation Bio Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2020 to Q2 2025.
  • Nuvation Bio Inc. Operating Income (Loss) for the quarter ending June 30, 2025 was -$63.6M, a 86.5% increase year-over-year.
  • Nuvation Bio Inc. Operating Income (Loss) for the twelve months ending June 30, 2025 was -$225M, a 58.2% increase year-over-year.
  • Nuvation Bio Inc. annual Operating Income (Loss) for 2024 was -$593M, a 494% decline from 2023.
  • Nuvation Bio Inc. annual Operating Income (Loss) for 2023 was -$99.8M, a 16.6% increase from 2022.
  • Nuvation Bio Inc. annual Operating Income (Loss) for 2022 was -$120M, a 28.3% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 -$225M -$63.6M +$407M +86.5% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-07
Q1 2025 -$631M -$59M -$38.8M -192% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-07
Q4 2024 -$593M -$53.9M -$33.1M -159% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-06
Q3 2024 -$560M -$48.1M -$21.8M -82.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 -$538M -$470M -$444M -1700% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-07
Q1 2024 -$93.5M -$20.2M +$6.32M +23.8% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-07
Q4 2023 -$99.8M -$20.8M +$3.5M +14.4% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-06
Q3 2023 -$103M -$26.3M +$3M +10.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 -$106M -$26.1M +$11.7M +31% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-05
Q1 2023 -$118M -$26.5M +$1.67M +5.93% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$120M -$24.3M +$5.28M +17.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 -$125M -$29.3M -$6.55M -28.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$118M -$37.9M -$17.4M -85.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 -$101M -$28.2M -$7.71M -37.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$93.3M -$29.6M -$15.8M -115% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-15
Q3 2021 -$77.5M -$22.8M -$11.2M -97.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$66.2M -$20.4M -$11.4M -127% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$54.8M -$20.5M -$11.3M -122% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$43.6M -$13.8M Oct 1, 2020 Dec 31, 2020 10-K 2022-02-28
Q3 2020 -$11.5M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$9.02M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$9.22M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.